Breathing life into Britain’s life-sciences industry

  • 📰 TheEconomist
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 92%

United States News News

United States United States Latest News,United States United States Headlines

Britain struggles to produce superstar life-sciences firms, or even the middling ones that build clusters. Private money and government efforts are needed

The response to the covid-19 pandemic has highlighted that research capability—and many believe the world to be on the cusp of a “biological century” driven by biotech innovation. On April 29th Matt Hancock, the secretary of state for health and social care, gave a speech about the government’s desire to turn Britain into a “life-sciences superpower”. By some measures, it already is. Only American scientists are more highly cited.

Firms that turn to public markets tend to cross the Atlantic, lured by the promise of heftier valuations. Recent ones include Immunocore and Vaccitech . “We’re seeingbiotech flourish,” says Alistair Campbell of Liberum, an investment bank. “It’s just not necessarily being listed on theBioIndustry Association finds that in total biotech firms last year raised £2.8bn, up from an average of £1.6bn over the past three years.

Successive governments have tried to make this happen using tax inducements and investment—with only some success before the pandemic. Now investors expect spending in new areas. “You’ve got this...concern about sovereignty of supply,” says Dr Roberts. “You start to think, ‘Hang on, there’s going to be a big manufacturing base we will have to build here.’”

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Is this Boris Johnson ?

Israel is killing innocent people. Stop Israeli brutality. Gaza Palestine

Comparing vaccines: country of origin, safety, price, efficacy, and approval Pfizer, Johnson & Johnson, Moderna, AstraZeneca, Sputnik V, Sinopharm, Bharat Biotech (COVAXIN), Medicago (CoVLP)

Tell me that’s not Borris Johnson...

NEED of a good crypto trader to manage your account or assist you in trading, with at least 90% winnings? I can help you manage your account perfectly with masterclass strategy. With average wins of 9 out of 10 trades daily, Inbox to know more

put the lime in the coconut...

Poorly titled article, how about companies like Avacta? They've just validated their Covid Antigen test (98% sensitivity, 99% specificity). They're also set to start the first human trials on their pro-doxorubicin chemo drug this June, based on hugely successful animal trials.

It’s dire, folks. As this photo shows, Boris Johnson is having to do the science himself.

I owe you an apology to ever doubt your sincerity and professionalism. It’s was just like a dream to me when I received my first payment. After my second payment it became a reality now after several payments it has become a way of life. Nancy_p7

Selective reporting again eh? odx ncyt gdr avct to name but a few.....

thanks for this news

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

As the overall job market stumbles back, women still struggle to recover lost employmentAs the job market stumbles back, women still struggle to recover lost employment. 'Policymaking has not accounted for the fact that people’s work lives and their personal lives are inextricably linked — if one suffers so does the other,' Sec. Yellen says. There will never be free daycare or free healthcare. They aren't a right in most of the world and there's no reason why they should be in the USA. No state has the money.
Source: NBCNews - 🏆 10. / 86 Read more »